CD5L and liver disorder: In order to address this issue, we developed and characterized a novel sandwich enzyme‐linked immunosorbent assay (ELISA) for human CD5L, assessed CD5L concentrations in serum samples from a circadian profile study, from patients with liver disease and women during pregnancy.